Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Bladder Cancer, Mesothelioma

Nicholas Vogelzang

MD

🏢Comprehensive Cancer Centers of Nevada🌐USA

Physician in Chief

62
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Nicholas Vogelzang has made contributions to GU oncology clinical research including work on MVAC chemotherapy for bladder cancer and on pemetrexed-cisplatin in mesothelioma. His extensive participation in GU oncology cooperative group trials across multiple decades has contributed to establishing several standard-of-care regimens.

Share:

🧪Research Fields 研究领域

bladder cancer chemotherapy
MVAC chemotherapy
mesothelioma pemetrexed
GU oncology clinical trials
cisplatin-based regimens

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Nicholas Vogelzang 的研究动态

Follow Nicholas Vogelzang's research updates

留下邮箱,当我们发布与 Nicholas Vogelzang(Comprehensive Cancer Centers of Nevada)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment